Literature DB >> 11545633

Optical coherence tomography demonstrates subretinal macular edema from papilledema.

V J Hoye1, A M Berrocal, T R Hedges, M L Amaro-Quireza.   

Abstract

OBJECTIVE: To evaluate macular changes in eyes with papilledema from increased intracranial pressure using optical coherence tomography (OCT).
METHODS: Fifty-five patients with papilledema seen during 1998 and 1999 were studied with OCT of the optic nerve and retinal nerve fiber layer. Nineteen of these also had OCT of the macula during periods of acute, subacute, or recurrent papilledema and were evaluated in detail for this report.
RESULTS: Seven patients had OCT evidence of subretinal fluid involving the macula. All had some reduction in visual acuity. The subretinal fluid appeared to arise from the peripapillary region, and all showed some improvement in central vision as the fluid resolved.
CONCLUSIONS: Subretinal fluid accumulations can cause decreased visual acuity in patients with papilledema. Optical coherence tomography can demonstrate subretinal fluid and can be used to follow the course of this important visual complication of papilledema.

Entities:  

Mesh:

Year:  2001        PMID: 11545633     DOI: 10.1001/archopht.119.9.1287

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography.

Authors:  Christopher Eckstein; Shiv Saidha; Elias S Sotirchos; Gita Byraiah; Michaela Seigo; Aleksandra Stankiewicz; Stephanie B Syc; E'tona Ford; Srilakshmi Sharma; Peter A Calabresi; Carlos A Pardo
Journal:  J Neurol       Date:  2012-01-04       Impact factor: 4.849

2.  Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.

Authors:  John J Chen; Matthew J Thurtell; Reid A Longmuir; Mona K Garvin; Jui-Kai Wang; Michael Wall; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

3.  Macular Involvement and Response to Steroid Therapy Demonstrated by Optical Coherence Tomography in Non-arteritic Anterior Ischaemic Optic Neuropathy.

Authors:  Sibel Demirel; Figen Batıoğlu; Yesim Gedik Oguz; Emin Özmert
Journal:  Neuroophthalmology       Date:  2013-07-25

4.  Syphilis mimicking idiopathic intracranial hypertension.

Authors:  Hanne Yri; Marianne Wegener; Rigmor Jensen
Journal:  BMJ Case Rep       Date:  2011-11-08

Review 5.  Management of idiopathic intracranial hypertension in pregnancy.

Authors:  Lachlan Andrew Byth; Karin Lust; Rosalind L Jeffree; Mark Paine; Lucie Voldanova; Ann-Maree Craven
Journal:  Obstet Med       Date:  2021-06-09

6.  Visual loss related to macular subretinal fluid and cystoid macular edema in HIV-related optic neuropathy.

Authors:  David Gautier; Valérie Rabier; Ghislaine Jallet; Dan Milea
Journal:  Int Ophthalmol       Date:  2012-05-13       Impact factor: 2.031

7.  Optical coherence tomography in papilledema and pseudopapilledema with and without optic nerve head drusen.

Authors:  Shikha Talwar Bassi; Kuppuswamy Parthasarthy Mohana
Journal:  Indian J Ophthalmol       Date:  2014-12       Impact factor: 1.848

8.  Profile and Determinants of Retinal Optical Intensity in Normal Eyes with Spectral Domain Optical Coherence Tomography.

Authors:  Binyao Chen; Enting Gao; Haoyu Chen; Jianling Yang; Fei Shi; Ce Zheng; Weifang Zhu; Dehui Xiang; Xinjian Chen; Mingzhi Zhang
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

9.  Electro-oculography in bilateral optic neuropathy.

Authors:  Padmini Dahanayake; Tharaka L Dassanayake; Manoji Pathirage; Saman Senanayake; Mike Sedgwick; Vajira Weerasinghe
Journal:  BMC Res Notes       Date:  2020-06-12

Review 10.  Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.

Authors:  Kirstin L Tawse; Thomas R Hedges; Marisa Gobuty; Carlos Mendoza-Santiesteban
Journal:  Br J Ophthalmol       Date:  2014-03-13       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.